biotech / news / / Newsweek
Regeneron will cut the price of its cholesterol-lowering treatment Praluent to $225, down from $537.
Regeneron will reduce its Praluent price to $225 from $537 on Trump's TrumpRx website.
KEY POINTS
- All new Regeneron medicines will receive Most Favored Nation pricing, matching lowest international drug prices.
- Regeneron is the 17th major drugmaker to sign a TrumpRx and MFN deal with the administration.
- Multiple Regeneron medications in clinical trials will also be subject to MFN pricing under this agreement.
COMPANIES
Summarized by Newsio from Newsweek. How we summarize →